Messy Financials, Lower Offers: Why Clean Reporting Changes Everything
Messy Financials, Lower Offers: Why Clean Reporting Changes Everything Key Takeaways Why Messy Financials Make Buyers Lower Their Offers When financial reporting is inconsistent, buyers rarely assume the best. They assume risk, delay, and possible earnings leakage. That is especially true in healthcare, where reimbursement complexity, provider dependency, and margin pressure already require closer scrutiny. […]
Read More
Healthcare CEO Guide: What Your Board or Partners Must Decide Before LOI
Healthcare CEO Guide: What Your Board or Partners Must Decide Before LOI Key Takeaways Why Alignment Must Happen Before LOI An LOI should confirm a shared strategy, not expose internal conflict. In 2025, 47% of directors said M&A was a strategic priority for their boards, showing how early governance matters in real transactions. Buyers also […]
Read More
How to Avoid Buyer Retrades: The Healthcare Company CEO’s Prevention Plan
How to Avoid Buyer Retrades: The Healthcare Company CEO’s Prevention Plan Key Takeaways Why Buyer Retrades Happen in Healthcare Deals A retrade happens when a buyer comes back after the LOI and asks for a lower price, tighter terms, or added protections. In healthcare, this usually follows diligence findings tied to billing, compliance, staffing, or […]
Read More
How to Package Healthcare Company Add-Backs the Right Way (Without Losing Trust)
How to Package Healthcare Company Add-Backs the Right Way (Without Losing Trust) Key Takeaways Why Add-Backs Become a Trust Issue In healthcare M&A, buyers do not automatically reject add-backs; they reject uncertainty. When adjustments feel vague, recurring, or poorly supported, trust drops fast. That is why sellers should prepare earnings support early, much like a […]
Read More
How Healthcare M&A Firms Package Add-Backs Without Damaging Credibility
How Healthcare M&A Firms Package Add-Backs Without Damaging Credibility Key Takeaways Why Add-Back Packaging Can Make or Break Deal Credibility In healthcare deals, buyers don’t hate add-backs—they hate unverified add-backs. The goal is a clean bridge from “books EBITDA” to “buyer-ready EBITDA” that can survive Quality of Earnings. Use an evidence-first mindset like QoE readiness […]
Read More
Healthcare CEO Guide: Handling Accounts Receivable and Working Capital in Smaller Deals
Healthcare CEO Guide: Handling Accounts Receivable and Working Capital in Smaller Deals Key Takeaways Why A/R Becomes a Deal Term In smaller practice transactions, buyers aren’t only buying EBITDA—they’re buying the ability to convert revenue into cash. If collections are slow or A/R quality is unclear, buyers protect themselves with working-capital targets, holdbacks, or post-close […]
Read More